UK to invest in research on evolving global health threats
30 September 2019
The UK’s chief medical officer Professor Dame Sally Davies has announced funding for projects to help combat antimicrobial resistance (AMR) and achieve global universal health coverage.
The funding includes: £6.2 million to strengthen existing surveillance systems tracking AMR trends across Africa and Asia; and £12 million to improve collaborations on health systems research between low- and middle-income countries and the UK.
Further reading: PharmaTimes
Author(s): Selina McKee
Effective Surveillance Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
